|
GTF2H2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.914100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.827810E-02 |
| Normal-vs-Stage2 |
6.147700E-02 |
| Normal-vs-Stage3 |
5.759800E-02 |
| Normal-vs-Stage4 |
6.948000E-02 |
| Stage1-vs-Stage2 |
4.278000E-01 |
| Stage1-vs-Stage3 |
3.938800E-01 |
| Stage1-vs-Stage4 |
6.353600E-01 |
| Stage2-vs-Stage3 |
9.739600E-01 |
| Stage2-vs-Stage4 |
9.140400E-01 |
| Stage3-vs-Stage4 |
9.382800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.016400E-02 |
| Normal-vs-AfricanAmerican |
1.505920E-02 |
| Normal-vs-Asian |
2.126500E-02 |
| Caucasian-vs-AfricanAmerican |
1.257760E-01 |
| Caucasian-vs-Asian |
4.175800E-01 |
| AfricanAmerican-vs-Asian |
6.638200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.083700E-02 |
| Normal-vs-Female |
8.185700E-02 |
| Male-vs-Female |
1.082390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.715600E-02 |
| Normal-vs-Extreme_Weight |
2.304000E-02 |
| Normal-vs-Obese |
6.424100E-02 |
| Normal-vs-Extreme_Obese |
1.441860E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.679600E-01 |
| Normal_Weight-vs-Obese |
3.145800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.431200E-01 |
| Extreme_Weight-vs-Obese |
2.253200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.533000E-01 |
| Obese-vs-Extreme_Obese |
2.586200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.424470E-02 |
| Normal-vs-Age(41-60Yrs) |
2.593800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.540000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.756700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.571600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.579800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.774800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.799600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.968300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.274300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.428000E-02 |
| Normal-VS-Type2 PRCC |
6.051500E-02 |
| Normal-VS-KIRP CIMP |
1.089540E-02 |
| Normal-VS-Unclassified PRCC |
3.458400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.151400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.792400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.528400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.922360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.313400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.105600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.556400E-02 |
| Normal-vs-N1 |
6.877800E-02 |
| Normal-vs-N2 |
1.265750E-02 |
| N0-vs-N1 |
8.305200E-01 |
| N0-vs-N2 |
3.255800E-01 |
| N1-vs-N2 |
2.585200E-01 |
|
|
